Randomized, phase II study of two doses of pemetrexed as first-line chemotherapy for locally advanced or metastatic breast cancer (MBC): Clinical results and exploratory pharmacogenomic analysis.

Title:: Randomized, phase II study of two doses of pemetrexed as first-line chemotherapy for locally advanced or metastatic breast cancer (MBC): Clinical results and exploratory pharmacogenomic analysis.
Document type:: Meeting Abstract
Author(s):: Llombart-Cussac, A; Martin, M; Harbeck, N; Anghel, R; Eniu, A; Melemed, A; Clark, R; Simms, L; Kaiser, C; Ma, D
Journal title abbreviation:: J Clin Oncol
Year:: 2006
Journal volume:: 24
Journal issue:: 18
Pages contribution:: 140S-140S
Language:: eng
Print-ISSN:: 0732-183X
TUM Institution:: Frauenklinik und Poliklinik
BibTeX

Occurrences: